Back to top
"JavaScript is a standard programming language that is included to provide interactive features, Kindly enable Javascript in your browser. For details visit help page"
भारत सरकार
Government of india
रसायन और उर्वरक मंत्रालय
Ministry of Chemicals and Fertilizers
Skip to main content
Search
The Web
PHARMACEUTICALS.GOV.IN
Search
A
+
A
A
-
A
A
हिन्दी
Site Logo
औषध विभाग
Department of
Pharmaceuticals
Menu
Home
About Us
About the Department
Business Allocation
Divisions
Policy (Pharmaceuticals)
Policy (Medical Devices)
Jan Aushadhi
Policy (Pricing)
International Cooperation
Foreign Direct Investment
Academia & Research
Integrated Finance Division and Budget
Public Sector Undertakings (PSU)
Rajbhasha
Parliament & Coordination
Establishment
Vigilance
Administration
Agencies Under Department
Who's Who
Organisation Chart
Precedent Book
Procurement Projections
Citizen Charter
RTI
RTI - ACT
CPIO'S
Proactive Disclosure
Auditor's Report
RTI-Online Application/ Appeal
Work Allocation and Committees
Channel of Submission
Acts
Niper Act, Rules, Statutes & Ordinance
Drugs (Prices Control) Order, 2013
Policies
Schemes
PRIP
Others
Finance & Budget
Chief Controller Of Accounts
Plan Schemes
Budget and Expenditure
Detailed Demand for Grants
Swachh Bharat
Reports
Annual Report
Study Report
Home Slider
Content
Home
>
Whats New
>
Whats New Archive
Documents/ Reports
Tenders
Recruitment
MOUs with PSUs
Media Gallery
Study Reports
Other Links
Review Orders
Annual Report
Important Links
Press Information Bureau
Hindi Shabdawali
STQC Certificate
What's New Archive
All Documents Archive
Title
Guidelines regarding Awards to the leading Pharma and Medical Devices Industry players - India Pharma 2022 & India Medical Devices 2022.
Notice regarding Awards to the leading Pharma and Medical Devices Industry players - India Pharma 2022 & India Medical Devices 2022
Pre-Bid meeting regarding Request for Proposal (RFP) for engagement of Asset Valuer for separate valuation to be held on 10.03.2022 (Time: 03:30 P.M.) in respect of HAL
Pre-Bid meeting regarding Request for Proposal (RFP) for engagement of Asset Valuer for separate valuation to be held on 11.03.2022 (Time: 03:30 P.M.) in respect of IDPL
Public Notice dated 28.02.2022 :Inviting details of local manufacturers of specific Drugs -reg.
Request for Proposal (RFP) for engagement of Asset Valuer for valuation of immovable & movable assets of Hindustan Antibiotics Ltd. (HAL) - under administrative control of MoCF-DoP
Request for Proposal (RFP) for engagement of Asset Valuer for separate valuation of immovable, and movable assets of Indian Drugs & Pharmaceutical Limited (IDPL) under administrative control of MoCF-DoP
List of approved applicants under PLI Scheme for Bulk Drug (Dated :20-01-2021)
Standards of Medical Devices
Public Notice dated 01.02.2022: Relaxation on Global Tender Enquiry (GTE) under Rule 161(iv) of General Financial Rules (GFRs) 2017 for procurement of Medical Devices - reg.
Hiring of Technical Consultant for Pharmaceuticals and Medical Devices.
Invitation of Applications under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) in the Country
List of approved applicants under PLI Scheme for Medical Devices
Press Notes regarding Approvals accorded under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country. Dated: 9th December, 2021
Press Notes regarding Approval accorded under PLI Scheme for Promotion of Domestic Manufacturing of Medical Devices. Dated: 9th December, 2021
Report of Swachhata Abhiyan Special Drive from 2nd to 31st October 2021
List of Approved Applicants under Production Linked Incentive (PLI) Scheme for Pharmaceuticals
Monthly Summary report for the month of November-2021
List of Approved Applicants under the the Production Linked Incentive (PLI) scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs)/ Active Pharmaceutical Ingredients (APIs) in India
Inviting details of local manufacturers of specific medical devices/equipments
Report & Action Plan on constitution day celebration in Department of Pharmaceuticals
Public Procurement Policy
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
Monthly Summary report for the Month of October-2021
Press Release regarding Selection of applicants under the Production Linked Incentive (PLI) scheme for Pharmaceuticals
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
FAQ: Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereofregarding.
Corrigendum: R.F.P. for Short Term Study and Long Term Study -Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
R.F.P. for Long Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
R.F.P. for Short Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
Regarding- Draft Policy to Catalyze Research & Development and Innovation in the Pharma - MedTech Sector in India
Report on Swacchata Pakhwada from 1-15 September, 2021
Monthly Summary report for the month of September-2021
Circulation of Draft Policy to Catalyze Research & Development and Innovation in the Pharma- MedTech Sector in India
R.F.P. for Long Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
R.F.P. for Short Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
Monthly Summary report for the month of August-2021
Filling up the post of Managing Director, Bengal Chemicals & Pharmaceuticals Limited (BCPL) on deputation basis through Search-cum-Selection Committee (SCSC).
Monthly Summary report for the month of July, 2021
Corrigendum under PLI scheme for Pharmaceuticals
Amendment in paragraph 18 of dpco, 2013
Filling up the post of Chief Executive Officer (CEO) in the Pharmaceutical and Medical Devices Bureau of India (PMBI), a Society under the aegis of Department of Pharmaceuticals, Government of India on deputation including short term contract.
Invitation of Applications for Ofloxacin under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in India.
Notice for Time Extension of PLI for Bulk Drug and PLI for Medical Devices
Order on Amendment in the Drugs (Prices Control) Order, 2013 for inclusion on Form VI
Notification regarding the revision of ceiling prices under para 18(i) of the Drugs (Prices Control) Order, 2013.
Monthly Summary report for the month of June, 2021
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »
Featured
औषध विभाग
Department of
